Giuseppe Procopio
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
- Oncology top 1%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Renal cell carcinoma treatment 177
- Prostate Cancer Treatment and Research 83
- Oncology 134
- Cancer Immunotherapy and Biomarkers 49
- Co-authors
- Elena Verzoni (147 shared papers)Emilio Bajetta (46 shared papers)Filippo de Braud (69 shared papers)Silke Gillessen (6 shared papers)Elena Castro (1 shared paper)Karim Fizazi (4 shared papers)Bertrand Tombal (3 shared papers)Piet Ost (1 shared paper)
- Journals
- Journal of Clinical Oncology (87 papers)Annals of Oncology (49 papers)Clinical Genitourinary Cancer (14 papers)Expert Review of Anticancer Therapy (10 papers)European Journal of Cancer (8 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Giuseppe Procopio
341 papers receiving 5.5k citations
Giuseppe Procopio's Hit Papers
Peers
Comparison fields: 5 of 106
- Pulmonary and Respiratory Medicine 2.9k
- Oncology 2.1k
- Cancer Research 853
- Neurology 479
- Epidemiology 942
Countries citing papers authored by Giuseppe Procopio
This map shows the geographic impact of Giuseppe Procopio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Procopio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Procopio more than expected).
Fields of papers citing papers by Giuseppe Procopio
This network shows the impact of papers produced by Giuseppe Procopio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Procopio. The network helps show where Giuseppe Procopio may publish in the future.
Co-authors
The 25 scholars most cited alongside Giuseppe Procopio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 364 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2020 | 614 |
| 2 | 1999 | 232 | |
| 3 | 2017 | 187 | |
| 4 | 2006 | 180 | |
| 5 | 2019 | 168 | |
| 6 | 2005 | 162 | |
| 7 | Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial Hit paper breakdown → | 2023 | 154 |
| 8 | 1998 | 132 | |
| 9 | 2021 | 131 | |
| 10 | 2011 | 110 | |
| 11 | 2002 | 91 | |
| 12 | 2011 | 78 | |
| 13 | 2013 | 72 | |
| 14 | 2013 | 69 | |
| 15 | 2005 | 64 | |
| 16 | 2006 | 60 | |
| 17 | 2011 | 59 | |
| 18 | 2022 | 55 | |
| 19 | 2009 | 55 | |
| 20 | 2016 | 50 |
About Giuseppe Procopio
Giuseppe Procopio is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 364 papers that have together received 5.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (177 papers), Prostate Cancer Treatment and Research (83 papers), Cancer Genomics and Diagnostics (66 papers), Cancer Immunotherapy and Biomarkers (49 papers), Renal and related cancers (42 papers), Radiopharmaceutical Chemistry and Applications (42 papers), Economic and Financial Impacts of Cancer (29 papers) and Bladder and Urothelial Cancer Treatments (26 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.9k citations), Oncology (2.1k citations), Cancer Research (853 citations), Neurology (479 citations) and Epidemiology (942 citations). Giuseppe Procopio has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Elena Verzoni, Emilio Bajetta, Filippo de Braud, Silke Gillessen, Elena Castro, Karim Fizazi, Bertrand Tombal, Piet Ost, Chris Parker and Axel Heidenreich. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Genitourinary Cancer, Expert Review of Anticancer Therapy and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.